Palepu A - Search Results

1

Staging for antiretroviral therapy among HIV-infected drug users.

Wood E, Hogg RS, Bonner S, Kerr T, Li K, Palepu A, Guillemi S, Schechter MT, Montaner JS. Wood E, et al. Among authors: palepu a. JAMA. 2004 Sep 8;292(10):1175-7. doi: 10.1001/jama.292.10.1175-b. JAMA. 2004. PMID: 15353528 No abstract available.

2

Barriers to use of free antiretroviral therapy in injection drug users.

Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, Schechter MT, Hogg RS. Strathdee SA, et al. Among authors: palepu a. JAMA. 1998 Aug 12;280(6):547-9. doi: 10.1001/jama.280.6.547. JAMA. 1998. PMID: 9707146

3

Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.

Palepu A, Tyndall M, Yip B, O'Shaughnessy MV, Hogg RS, Montaner JS. Palepu A, et al. J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):522-6. doi: 10.1097/00126334-200304150-00009. J Acquir Immune Defic Syndr. 2003. PMID: 12679704

4

Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.

Palepu A, Tyndall MW, Li K, Yip B, O'Shaughnessy MV, Schechter MT, Montaner JS, Hogg RS. Palepu A, et al. J Urban Health. 2003 Dec;80(4):667-75. doi: 10.1093/jurban/jtg073. J Urban Health. 2003. PMID: 14709714 Free PMC article.

5

Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.

Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E. Kerr T, et al. Among authors: palepu a. Antivir Ther. 2004 Jun;9(3):407-14. Antivir Ther. 2004. PMID: 15259903

6

Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.

Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Palepu A, et al. Antivir Ther. 2004 Oct;9(5):713-9. Antivir Ther. 2004. PMID: 15535408

7

Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users.

Wood E, Hogg RS, Kerr T, Palepu A, Zhang R, Montaner JS. Wood E, et al. Among authors: palepu a. AIDS. 2005 May 20;19(8):837-9. doi: 10.1097/01.aids.0000168982.20456.eb. AIDS. 2005. PMID: 15867502

8

Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.

Wood E, Kerr T, Palepu A, Zhang R, Strathdee SA, Tyndall MW, Montaner JS, Hogg RS. Wood E, et al. Among authors: palepu a. J Infect. 2006 Apr;52(4):233-6. doi: 10.1016/j.jinf.2005.07.008. Epub 2005 Sep 19. J Infect. 2006. PMID: 16169594

9

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.

Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS. Palepu A, et al. Drug Alcohol Depend. 2006 Sep 15;84(2):188-94. doi: 10.1016/j.drugalcdep.2006.02.003. Epub 2006 Mar 20. Drug Alcohol Depend. 2006. PMID: 16542797

10

Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users.

Wood E, Kerr T, Hogg RS, Palepu A, Zhang R, Strathdee SA, Montaner JS. Wood E, et al. Among authors: palepu a. Drug Alcohol Rev. 2006 Sep;25(5):451-4. doi: 10.1080/09595230600883313. Drug Alcohol Rev. 2006. PMID: 16939941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters